Docking studies of phthalimide pharmacophore as a sodium channel blocker

Iranian Journal of Basic Medical Sciences

Volumn 16, Issue 9, 2013, Pages 1016-1021

  Iman, Maryam ^a   Saadabadi, Atefeh ^b   Davood, Asghar ^b  

^a BAQIYATALLAH UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b ISLAMIC AZAD UNIVERSITY   (Iran)

Author keywords

Anticonvulsant; Docking; Molecular modeling; Na channel; Phthalimide

Indexed keywords

BATRACHOTOXIN; PHTHALIMIDE;

ANTICONVULSANT ACTIVITY; ARTICLE; COMPUTER PROGRAM; COMPUTER SIMULATION; CONFORMATIONAL TRANSITION; DRUG STRUCTURE; MOLECULAR DOCKING; MOLECULAR MODEL; PHARMACOPHORE;

EID: 84884559306     PISSN: 20083866     EISSN: 20083874     Source Type: Journal    
DOI: None     Document Type: Article

References (17)

1. Stefan H, Feuerstein T. Novel anticonvulsant drugs. Pharmacol Ther 2007; 113:165.
2. Donner EJ, Snead OC. New generation anticonvulsants for the treatment of epilepsy in children. Neuro Rx 2006; 3:170.
3. Brodie MJ. Antiepileptic drug therapy the story so far. Seizure 2010; 19:650-55.
4. Lacoste L, Bartolucci S, Lapointey J. Pentylenetetrazole inhibits glutamate dehydrogenase and a separate aminotransferase, and stimulates GABA aminotransferase in homogenates from rat cerebral cortex. J Physiol Pharmacol 1988; 66:1135-1138.
5. Yuesheng W, Jones PJ, Batts TW, Landry V, Patel MK, Brown ML. Ligand-based design and synthesis of novel sodium channel blockers from a combined phenytoin-lidocainepharmacophore. Bio org Med Chem 2009; 17:7064-7072.
6. Goldin AL. Resurgence of sodium channel research. Annu Rev Physiol 2001; 63:871.
7. Catterall WA, Goldin AL, Waxman SG. International Union of Pharmacology. XLVII. Nomenclature and structure-function relationships of voltage-gated sodium channels. Pharmacol Rev 2005; 57:397-409.
8. Vamecq J, Bac P, Herrenknecht CHJ, Maurois P, Delcourt P, Stables JP. Synthesis and anticonvulsant and neurotoxic properties of substituted N-phenyl derivatives of the phthalimide pharmacophore. J Med Chem 2000; 43:1311-1319.
9. Małgorzata W, Katarzyna KK. Synthesis and anticonvulsant evaluation of some N-substituted phthalimides. Acta Pol Pharm Drug Res 2009; 66: 249-257.
10. Davood A, Iman M. Docking and QSAR studies of b-phenylethylidenehydrazine derivatives as a Gamma-aminobutyric acid amino transferase inhibitor. Med Chem Res 2011; 20:955-961.
11. Lipkind GM, Fozzard HA. Molecular modeling of local anesthetic drug binding by voltage-gated sodium channels. Mol Pharmacol 2005; 68:1611-1622.
12. Morris GM, Goodsell, DS, Pique ME, Lindstrom WL, Huey R, Forli S, et al. AutoDock4 and autoDockTools4: automated docking with selective receptor flexibility. J Comput Chem 2009; 30: 2785-2291.
13. 2+ channel: model construction and docking calculations. J Med Chem 2007; 50:1504-1113.
14. Storici P, De Biase D, Bossa F, Bruno S, Mozzarelli A, Peneff C, et al. Structures of {gamma}-aminobutyric acid (GABA) aminotransferase, a pyridoxal50-phosphate, and [2Fe-2S] cluster-containing enzyme, complexedwith {gamma}-ethynyl-GABA and with the antiepilepsydrug vigabatrin. J Biol Chem 2004; 279:363.
15. Davood A, Nematollahi A, Iman M, Shafiee A. Synthesis and docking studies of new 1,4-dihydropyridines containing 4-(5)-chloro-2-ethyl-5-(4)-imidazolyl substituent as novel calcium channel agonist. Arch Pharm Res 2009; 32:481-487.
16. OReilly AO, Khambay BPS, Williamson MS, Field LM, WAllace BA, Emyr Davies TG. Modelling insecticide-binding sites in the voltage-gated sodium channel. Biochem J 2006; 396:255-263.
17. Huey R, Morris GM. Using Autodock 4 with Autodocktools: A Tutorial. The Scripps Research Institute, USA. 2008; 54-56.